Amgen and UCB resubmit BLA for EVENITY to transform osteoporosis treatment in postmenopausal women
Amgen, in collaboration with UCB, has announced the resubmission of the biologics license application (BLA) for their osteoporosis…
FDA sets review date for Ironshore Pharmaceuticals’ ADHD drug HLD200
Ironshore Pharmaceuticals & Development, a subsidiary of Highland Therapeutics, has reached a significant milestone with the U.S. Food…
Antoxerene and Juvenescence launch FoxBio to develop anti-aging drugs
Antoxerene, a pharmaceutical company dedicated to developing senolytic drugs, has partnered with investment firm Juvenescence to form a…
FDA removes clinical hold on Advaxis’ Axalimogene Filolisbac, Durvalumab combo trial
Advaxis, a biotech firm based in New Jersey, announced a significant regulatory update as the U.S. Food and…
Xencor initiates Phase 1 trial of XmAb20717 for advanced solid tumors
Xencor, a prominent biopharmaceutical company based in Monrovia, California, has recently dosed the first patient in a Phase…
Modus Therapeutics secures $15.7m for sickle cell disease drug development
Modus Therapeutics, a Swedish biotech firm specializing in sickle cell disease therapies, has successfully raised SEK 140 million…
Prevacus partners with Blinktbi for advanced concussion drug trials
Prevacus, a leading US biopharmaceutical company, has announced a strategic partnership with medical device company Blinktbi, utilizing their…
Citius Pharmaceuticals expands scientific advisory board to enhance focus on infectious disease treatments
Citius Pharmaceuticals, a specialty pharmaceutical company based in New Jersey, has announced the addition of Dr. Lawrence Mermel…
Siga Technologies secures Tecovirimat FDA approval for smallpox treatment
Siga Technologies has achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) approval of its…
Astellas, Pfizer bag Xtandi FDA approval for non-metastatic CRPC
In a significant development, Astellas Pharma and Pfizer have announced that the U.S. Food and Drug Administration (FDA)…